Market for Active Pharmaceutical Ingredients in Japan - Forecast and Analysis 2018
Japan is one of the biggest pharmaceutical markets in the work and the industry is expected to keep growing at a moderate pace in the coming years. As the Japanese population grows older as compared to other markets, the government has been responding to its aging population by easing several regulations and also introducing innovative new drugs into the market.
It is expected that the pharmaceutical market in Japan, worth just under USD 70 billion at the end of 2016, will cross USD 73 billion by 2021. In 2017, the Japanese market for active pharmaceutical ingredients (APIs) was one of the biggest in terms of revenues and had a share of nearly 55% of the global API industry. However, due to severe fluctuations in the Japanese currency against the US dollar as well as the high level of maturity evident in the Japanese pharmaceutical sector, it is expected that the market will grow at a slower than usual rate in the coming years.
Aruvian Research analyzes the market for APIs in Japan in its research report Market for Active Pharmaceutical Ingredients in Japan – Forecast and Analysis 2018. The data covered in this report ranges from 2008 till 2020. Let us take a look at what the report focusses on.
The report begins with an introduction to Active Pharmaceutical Ingredients and then moves on to briefly analyze the global market for active pharmaceutical ingredients. We include an overview of the global market for APIs and a look at the global market's revenues.
Section D of the report analyzes the market for active pharmaceutical ingredients in Asia Pacific through an industry overview, industry revenues, and a look at the various therapeutic applications of APIs in the Asia Pacific region. Impacts on the Asia Pacific active pharmaceutical ingredients market are also analyzed.
With section E, we begin our analysis of the market for active pharmaceutical ingredients in Japan. This section analyzes the industry through basic statistics and industry revenues. Industry segmentation through the biotech segment and the synthetic API market in Japan is included in the report, along with a forecast of the industry till 2020.
An analysis of the major industry players, both global and domestic, are included in the report. The major players are analyzed through a business segment profile, a look at their major products and services, and a SWOT analysis. The analysis looks at the top companies operating in the Japanese API market.
Research methodology for the report concludes this comprehensive report on the market for active pharmaceutical ingredients in Japan till 2020.
It is expected that the pharmaceutical market in Japan, worth just under USD 70 billion at the end of 2016, will cross USD 73 billion by 2021. In 2017, the Japanese market for active pharmaceutical ingredients (APIs) was one of the biggest in terms of revenues and had a share of nearly 55% of the global API industry. However, due to severe fluctuations in the Japanese currency against the US dollar as well as the high level of maturity evident in the Japanese pharmaceutical sector, it is expected that the market will grow at a slower than usual rate in the coming years.
Aruvian Research analyzes the market for APIs in Japan in its research report Market for Active Pharmaceutical Ingredients in Japan – Forecast and Analysis 2018. The data covered in this report ranges from 2008 till 2020. Let us take a look at what the report focusses on.
The report begins with an introduction to Active Pharmaceutical Ingredients and then moves on to briefly analyze the global market for active pharmaceutical ingredients. We include an overview of the global market for APIs and a look at the global market's revenues.
Section D of the report analyzes the market for active pharmaceutical ingredients in Asia Pacific through an industry overview, industry revenues, and a look at the various therapeutic applications of APIs in the Asia Pacific region. Impacts on the Asia Pacific active pharmaceutical ingredients market are also analyzed.
With section E, we begin our analysis of the market for active pharmaceutical ingredients in Japan. This section analyzes the industry through basic statistics and industry revenues. Industry segmentation through the biotech segment and the synthetic API market in Japan is included in the report, along with a forecast of the industry till 2020.
An analysis of the major industry players, both global and domestic, are included in the report. The major players are analyzed through a business segment profile, a look at their major products and services, and a SWOT analysis. The analysis looks at the top companies operating in the Japanese API market.
Research methodology for the report concludes this comprehensive report on the market for active pharmaceutical ingredients in Japan till 2020.
A. EXECUTIVE SUMMARY
B. INTRODUCTION TO ACTIVE PHARMACEUTICAL INGREDIENTS
C. GLOBAL MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENTS (APIS)
C.1 Industry Overview
C.2 Industry Revenues
D. MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENTS (APIS) IN ASIA PACIFIC
D.1 Industry Overview
D.2 Industry Revenues
D.3 Therapeutic Applications of API in Asia Pacific
D.4 Impacts on the Industry
E. MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENTS (APIS) IN JAPAN
E.1 Industry Overview
E.2 Industry Revenues
F. API MARKET IN JAPAN: INDUSTRY SEGMENTATION
F.1 Overview
F.2 Biotech API Market in Japan
F.3 Synthetic API Market in Japan
G. MAJOR INDUSTRY PLAYERS
G.1 Allergan Plc
G.1.1 Business Profile
G.1.2 Major Products & Services
G.1.3 SWOT Analysis
G.2 BASF SE
G.2.1 Business Profile
G.2.2 Major Products & Services
G.2.3 SWOT Analysis
G.3 Boehringer Ingelheim GmbH
G.3.1 Business Profile
G.3.2 Major Products & Services
G.3.3 SWOT Analysis
G.4 Bristol-Myers Squibb Company
G.4.1 Business Profile
G.4.2 Major Products & Services
G.4.3 SWOT Analysis
G.5 Daiichi Sankyo Company, Limited
G.5.1 Business Profile
G.5.2 Major Products & Services
G.5.3 SWOT Analysis
G.6 Lupin Limited
G.6.1 Business Profile
G.6.2 Major Products & Services
G.6.3 SWOT Analysis
G.7 Novartis AG
G.7.1 Business Profile
G.7.2 Major Products & Services
G.7.3 SWOT Analysis
G.8 Pfizer Inc.
G.8.1 Business Profile
G.8.2 Major Products & Services
G.8.3 SWOT Analysis
G.9 Teva Pharmaceutical Industries Limited
G.9.1 Business Profile
G.9.2 Major Products & Services
G.9.3 SWOT Analysis
G.10 Aurobindo Pharma
G.11 Cipla Ltd
G.12 Dr. Reddy's Laboratories Limited
G.13 Medtronic Plc
G.14 Mylan Inc
G.15 Ranbaxy Laboratories
G.16 Sun Pharmaceutical Industries Limited
H. GLOSSARY OF TERMS
I. RESEARCH METHODOLOGY
B. INTRODUCTION TO ACTIVE PHARMACEUTICAL INGREDIENTS
C. GLOBAL MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENTS (APIS)
C.1 Industry Overview
C.2 Industry Revenues
D. MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENTS (APIS) IN ASIA PACIFIC
D.1 Industry Overview
D.2 Industry Revenues
D.3 Therapeutic Applications of API in Asia Pacific
D.4 Impacts on the Industry
E. MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENTS (APIS) IN JAPAN
E.1 Industry Overview
E.2 Industry Revenues
F. API MARKET IN JAPAN: INDUSTRY SEGMENTATION
F.1 Overview
F.2 Biotech API Market in Japan
F.3 Synthetic API Market in Japan
G. MAJOR INDUSTRY PLAYERS
G.1 Allergan Plc
G.1.1 Business Profile
G.1.2 Major Products & Services
G.1.3 SWOT Analysis
G.2 BASF SE
G.2.1 Business Profile
G.2.2 Major Products & Services
G.2.3 SWOT Analysis
G.3 Boehringer Ingelheim GmbH
G.3.1 Business Profile
G.3.2 Major Products & Services
G.3.3 SWOT Analysis
G.4 Bristol-Myers Squibb Company
G.4.1 Business Profile
G.4.2 Major Products & Services
G.4.3 SWOT Analysis
G.5 Daiichi Sankyo Company, Limited
G.5.1 Business Profile
G.5.2 Major Products & Services
G.5.3 SWOT Analysis
G.6 Lupin Limited
G.6.1 Business Profile
G.6.2 Major Products & Services
G.6.3 SWOT Analysis
G.7 Novartis AG
G.7.1 Business Profile
G.7.2 Major Products & Services
G.7.3 SWOT Analysis
G.8 Pfizer Inc.
G.8.1 Business Profile
G.8.2 Major Products & Services
G.8.3 SWOT Analysis
G.9 Teva Pharmaceutical Industries Limited
G.9.1 Business Profile
G.9.2 Major Products & Services
G.9.3 SWOT Analysis
G.10 Aurobindo Pharma
G.11 Cipla Ltd
G.12 Dr. Reddy's Laboratories Limited
G.13 Medtronic Plc
G.14 Mylan Inc
G.15 Ranbaxy Laboratories
G.16 Sun Pharmaceutical Industries Limited
H. GLOSSARY OF TERMS
I. RESEARCH METHODOLOGY
LIST OF FIGURES
Figure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Figure 2: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
Figure 3: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
Figure 4: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2008-2020
Figure 5: Product Type & Revenue Share of the API Market in Japan (%), 2008-2020
Figure 6: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2008-2020
Figure 7: Share of the Biotech API Market in Japan by Application Sector (%), 2008-2020
Figure 8: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2008-2020
Figure 9: Share of the Synthetic API Market in Japan by Application Sector (%), 2008-2020
Figure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Figure 2: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
Figure 3: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
Figure 4: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2008-2020
Figure 5: Product Type & Revenue Share of the API Market in Japan (%), 2008-2020
Figure 6: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2008-2020
Figure 7: Share of the Biotech API Market in Japan by Application Sector (%), 2008-2020
Figure 8: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2008-2020
Figure 9: Share of the Synthetic API Market in Japan by Application Sector (%), 2008-2020
LIST OF TABLES
Table 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Table 2: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
Table 3: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
Table 4: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2008-2020
Table 5: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2008-2020
Table 6: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2008-2020
Table 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Table 2: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
Table 3: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
Table 4: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2008-2020
Table 5: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2008-2020
Table 6: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2008-2020
